Explora’s Rapid Growth Profiled in the San Diego Business Journal

December 12, 2017

SAN DIEGO, CA — Richard Lin, CEO of Explora BioLabs, was interviewed for a front page article entitled “CRO Navigates Tough Preclinical Testing Stage for Companies,” published in the December 4-10, 2017 issue of the San Diego Business Journal. As stated in the article by Jared Whitlock, “Explora’s services are in demand, particularly among small … Read More »

Explora BioLabs Establishes Presence in Bay Area

September 5, 2017

SOUTH SAN FRANCISCO, CA — Explora BioLabs, the West Coast’s leading preclinical facility operator and service provider, announces the opening of its flagship pharmacology incubator in South San Francisco. This 18,000 square foot facility, located in the Genesis-SSF tower in the heart of the region’s largest biotech cluster, provides high quality workspace for clients’ pharmacology … Read More »

Explora BioLabs Opens Fifth Preclinical Pharmacology Facility

December 5, 2016

SAN DIEGO, CA — Explora BioLabs, a leading West Coast preclinical contract research organization (CRO), announces the opening of its newly-built 5,000 square foot in vivo pharmacology facility in the University Town Center (UTC) life sciences cluster of San Diego. This facility, within the Genesis Campus Point life sciences complex, will provide state-of-the-art housing for rodents used … Read More »

Explora BioLabs to Open Bay Area Preclinical Pharmacology Facility

September 12, 2016

South San Francisco and San Diego, CA — Explora BioLabs, a preclinical facility operator and service provider headquartered in San Diego, announces its expansion into South San Francisco. Explora has leased approximately 18,000 square feet of purpose-built pharmacology space in the landmark Genesis SSF tower, located at One Tower Place along Highway 101, bordering the … Read More »

Explora BioLabs Attending Boston RESI Conference

September 7, 2016

Explora BioLabs’ CEO, Richard Lin, will be attending the Redefining Early Stage Investments (RESI) Conference in Boston on September 13, 2016. This conference is the 10th in an ongoing conference series that has a stated goal of “establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding.” At the conference, … Read More »